KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 250 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,211 | +65.5% | 6,986 | -11.6% | 0.02% | +63.6% |
| Q3 2023 | $1,336 | -15.8% | 7,899 | +8.0% | 0.01% | -15.4% |
| Q2 2023 | $1,586 | +95.1% | 7,315 | +63.4% | 0.01% | +85.7% |
| Q1 2023 | $813 | -16.6% | 4,478 | -9.8% | 0.01% | -22.2% |
| Q4 2022 | $975 | -99.9% | 4,962 | +1.9% | 0.01% | -18.2% |
| Q3 2022 | $1,095,000 | +108.2% | 4,869 | +17.2% | 0.01% | +120.0% |
| Q2 2022 | $526,000 | +14.1% | 4,155 | +14.3% | 0.01% | +25.0% |
| Q1 2022 | $461,000 | -55.0% | 3,634 | -53.5% | 0.00% | 0.0% |
| Q4 2021 | $1,024,000 | +112.0% | 7,818 | +98.0% | 0.00% | 0.0% |
| Q3 2021 | $483,000 | +1.0% | 3,949 | -5.8% | 0.00% | 0.0% |
| Q2 2021 | $478,000 | +77.0% | 4,192 | +86.7% | 0.00% | -60.0% |
| Q1 2021 | $270,000 | +7.6% | 2,245 | -9.1% | 0.01% | 0.0% |
| Q4 2020 | $251,000 | -9.4% | 2,469 | -0.6% | 0.01% | -23.1% |
| Q2 2020 | $277,000 | – | 2,483 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |